US EditionPublished • loading... • Updated
CT-Based Risk Scoring System Outperforms AJCC TNM Staging for Predicting Recurrence of Pancreatic Ductal Adenocarcinoma
Summary by diagnosticimaging.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
CT-Based Risk Scoring System Outperforms AJCC TNM Staging for Predicting Recurrence of Pancreatic Ductal Adenocarcinoma
In comparison to American Joint Committee on Cancer (AJCC) TNM staging, an emerging CT-based scoring system for assessing early recurrence of pancreatic ductal adenocarcinoma demonstrated over a 22 percent higher AUC in testing and external validation cohorts in a new study.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
